Mangat Panna, Goswami Kartika, Solanki Mandeep, Rajput Neha
Department of Conservative Dentistry and Endodontics, Kalka Dental College and Hospital, Meerut, Uttar Pradesh, India.
J Conserv Dent Endod. 2025 Jan;28(1):78-83. doi: 10.4103/JCDE.JCDE_575_24. Epub 2025 Jan 13.
Indirect pulp capping (IPC) represents a pivotal therapeutic intervention directed toward preservation of pulp vitality, achieved through the placement of a biocompatible, bioactive material over the affected dentin to protect the pulp from further insult and encourage healing.
This study aimed to evaluate the clinical and radiographical success rates of Biodentin versus light-cured mineral trioxide aggregate (MTA) when used as an IPC agents. Evaluation was done on the basis of prognosis of the treatment after a period of 1 year.
This randomized controlled clinical trial was based on a cohort of 20 individuals with deep carious lesions being subsequently divided into two experimental groups of ten cases each. Group I - Biodentin and Group II - Light cured-MTA as pulp capping agents, respectively. Clinical and radiographical assessment was done at baseline, 1, 2, 3, 6 months, and 1 year.
Statistical analysis with the Chi-square test showed no statistically significant difference between the groups. The overall success rate of 1-year follow-up for both Biodentine group and Light-cured MTA group was 93.33%.
The results of this randomized controlled clinical trial support promising success of IPC independent of the pulp capping material used as the findings underscore a significant decrease in postoperative pain levels compared to preoperative states across all cases. However, more studies with long-term follow-ups are required.
间接盖髓术（IPC）是一种关键的治疗干预措施，旨在通过在受影响的牙本质上放置生物相容性、生物活性材料来保护牙髓活力，防止牙髓受到进一步损伤并促进愈合。
本研究旨在评估生物活性牙本质（Biodentin）与光固化三氧化矿物凝聚体（MTA）作为间接盖髓剂时的临床和影像学成功率。在1年的治疗期后，根据治疗预后进行评估。
本随机对照临床试验以20例患有深龋病变的个体为队列，随后将其分为两个实验组，每组10例。第一组使用生物活性牙本质，第二组使用光固化MTA作为盖髓剂。在基线、1、2、3、6个月和1年时进行临床和影像学评估。
卡方检验的统计分析表明两组之间无统计学显著差异。生物活性牙本质组和光固化MTA组1年随访的总体成功率均为93.33%。
本随机对照临床试验的结果支持间接盖髓术具有良好的成功率，与所使用的盖髓材料无关，因为研究结果强调所有病例术后疼痛水平与术前状态相比显著降低。然而，需要更多的长期随访研究。
